Metraipolis › archive › dc_2fcedf5c9846
Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis — Europe PMC PMID:41743950
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41743950
- DOI
- 10.3389/fonc.2026.1656688
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T23:36:28.039Z
- SHA-256 of the archived text
b73330eeb0f6516c93b98d7ba80933095e15d87ee544bb884a9a0eb4d50cbbfe- Stable URL of this page
https://metraipolis.com/documento/dc_2fcedf5c9846
How to cite
Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis — Europe PMC PMID:41743950 — Europe PMC (en), https://europepmc.org/article/MED/41743950 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fcedf5c9846 (Metraipolis archive dc_2fcedf5c9846, sha256 b73330eeb0f6516c93b98d7ba80933095e15d87ee544bb884a9a0eb4d50cbbfe)
BibTeX
@misc{dc2fcedf5c9846,
title = {Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis — Europe PMC PMID:41743950},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41743950},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fcedf5c9846; sha256 b73330eeb0f6516c93b98d7ba80933095e15d87ee544bb884a9a0eb4d50cbbfe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41743950. Agents can read the archived copy with the MCP tool read_document.